RxDoctor Payments Data

Peter Riznyk, DPM

Sports Medicine · Orchard Park, NYNPI 1730168667

Payments from drug & device makers

$3,142in general payments, 2019–2025

Across 32 payments — averaging $98.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$480
  • Amgen$473
  • Stryker$396
  • Treace Medical Concepts, Inc.$271
  • Smith+Nephew$247
  • Prodigy Surgical Distribution, Inc.$179
  • plus $1K from 9 others

What the payments were for

  • Speaking & faculty fees$1254%
  • Food & beverage$3,01796%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,142 in reported general payments places this provider in the 60th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York

Medicare billing

Part B allowed, 2024
$75,118
Medicare patients
364
Services billed
1,779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.11$4,648
CiclopiroxCiclopirox Olamine140$3,049
Triamcinolone Acetonide15$563
Fluconazole43$558
Terbinafine Hcl116$535
Ammonium Lactate13$293
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$292
Meloxicam77$241
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$133
Clindamycin Hcl15$127
Celecoxib13$71

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$247$4,64811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 403 sports medicine providers in New York.

Other sports medicine in Orchard Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →